These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21925844)

  • 1. Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.
    Soon RL; Nation RL; Harper M; Adler B; Boyce JD; Tan CH; Li J; Larson I
    Int J Antimicrob Agents; 2011 Dec; 38(6):493-501. PubMed ID: 21925844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic force microscopy investigation of the morphology and topography of colistin-heteroresistant Acinetobacter baumannii strains as a function of growth phase and in response to colistin treatment.
    Soon RL; Nation RL; Hartley PG; Larson I; Li J
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4979-86. PubMed ID: 19786595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
    Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
    J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implications.
    Soon RL; Li J; Boyce JD; Harper M; Adler B; Larson I; Nation RL
    J Appl Microbiol; 2012 Oct; 113(4):940-51. PubMed ID: 22574702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii.
    Lee JY; Lee H; Park M; Cha CJ; Shin D; Ko KS
    Clin Microbiol Infect; 2019 Sep; 25(9):1156.e1-1156.e7. PubMed ID: 30790686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
    Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic and phenotypic studies of bicarinalin, BP100 and colistin action on Acinetobacter baumannii.
    Eales MG; Ferrari E; Goddard AD; Lancaster L; Sanderson P; Miller C
    Res Microbiol; 2018; 169(6):296-302. PubMed ID: 29751064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
    Liu B; Liu Y; Di X; Zhang X; Wang R; Bai Y; Wang J
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):451-6. PubMed ID: 25229285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.
    Moffatt JH; Harper M; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2011 Jun; 55(6):3022-4. PubMed ID: 21402838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.
    Henry R; Vithanage N; Harrison P; Seemann T; Coutts S; Moffatt JH; Nation RL; Li J; Harper M; Adler B; Boyce JD
    Antimicrob Agents Chemother; 2012 Jan; 56(1):59-69. PubMed ID: 22024825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid determination of colistin resistance in clinical strains of Acinetobacter baumannii by use of the micromax assay.
    Tamayo M; Santiso R; Otero F; Bou G; Lepe JA; McConnell MJ; Cisneros JM; Gosálvez J; Fernández JL
    J Clin Microbiol; 2013 Nov; 51(11):3675-82. PubMed ID: 23985913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.